High-Throughput Screening (HTS)
Discovery - Biology
The High Volume Biology group advances the identification of novel modulators of targets by designing, optimizing, and running high-throughput screening (HTS) campaigns that deliver the critical starting points for therapeutic optimization.
We have a seasoned team of scientists with over eight decades of combined experience in drug discovery research and HTS, with expertise spanning HTS assay development, assay optimization, assay miniaturization, and hit-to-lead optimization support, including automated compound dose response follow-up and compound profiling. The team employs multiple robotic, liquid handling and detection platforms, along with robust processes, to deliver the highest quality results.
Our HTS capabilities include: